{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:52:09Z","timestamp":1791301929254,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["No.2017ZX10105001"],"award-info":[{"award-number":["No.2017ZX10105001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disorder across the world, and non-invasive evaluation approaches are in need to assess NAFLD disease progression. Serum ferritin has been proposed as one of the biomarkers for NAFLD diagnosis in previous studies. This systematic review aims to identify, report, and synthesize studies that investigated the association of serum ferritin level with the various stages of NAFLD among the adult population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Three databases \u2013 MEDLINE, EMBASE, and Scopus \u2013 were systematically searched to obtain potentially relevant publications before July 2022. No restrictions were applied to geographical region, study design, publication type and language. The association between serum ferritin level or different ferritin categories and the various stages of NAFLD was the primary outcome of interest. Title and abstract screenings, data extraction and coding, and quality assessment were independently completed by two authors with discrepancies resolved through discussion with a third author.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-two studies were included and heterogeneity was considerable. The associations between serum ferritin level and the stages of hepatic steatosis, fibrosis, inflammation and ballooning and the occurrence of non-alcoholic steatohepatitis (NASH) were investigated but inconsistent associations were reported. Most studies identified serum ferritin to be a predictor of advanced NAFLD, while several revealed the opposite end.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serum ferritin could be considered to act as a non-invasive biomarker for assessing various stages of NAFLD. Nevertheless, further studies are still in need to confirm its predictive value since this study reported inconsistent associations based on the qualitative synthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>http:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:ext-link>, identifier: CRD42021275630.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.934989","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:36:33Z","timestamp":1659501393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review"],"prefix":"10.3389","volume":"9","author":[{"given":"Huanqiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol Baltim Md."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","article-title":"Prevalence of nonalcoholic fatty liver disease and economy","volume":"60","author":"Zhu","year":"2015","journal-title":"Dig Dis Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatol Baltim Md."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatol Baltim Md"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.3748\/wjg.v22.i36.8226","article-title":"Clinical guidelines of non-alcoholic fatty liver disease: a systematic review","volume":"22","author":"Zhu","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"IV1","DOI":"10.1136\/gut.45.2008.iv1","article-title":"Guidelines on the use of liver biopsy in clinical practice","volume":"45","author":"Grant","year":"1999","journal-title":"Gut."},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0039-1693114","article-title":"Hyperferritinemia in nonalcoholic fatty liver disease: iron accumulation or inflammation?","volume":"39","author":"Moris","year":"2019","journal-title":"Semin Liver Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7718","DOI":"10.3748\/wjg.v20.i24.7718","article-title":"Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease","volume":"20","author":"Hu","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/ijpvm.IJPVM_274_19","article-title":"Predictors of nonalcoholic fatty liver disease among middle-aged Iranians","volume":"11","author":"Etminani","year":"2020","journal-title":"Int J Prev Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2050-7771-1-7","article-title":"Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD","volume":"1","author":"Pearce","year":"2013","journal-title":"Biomark Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"46ps42","DOI":"10.1126\/scitranslmed.3001249","article-title":"Recommendations for biomarker identification and qualification in clinical proteomics","volume":"2","author":"Mischak","year":"2010","journal-title":"Sci Transl Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.cgh.2013.11.035","article-title":"Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"12","author":"Angulo","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatol Baltim Md."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/liv.14096","article-title":"Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease","volume":"39","author":"Buzzetti","year":"2019","journal-title":"Liver Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatol Baltim Md."},{"key":"B23","first-page":"277","article-title":"Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease","volume":"70","author":"Canbakan","year":"2007","journal-title":"Acta Gastro-Enterol Belg."},{"key":"B24","first-page":"53","article-title":"Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease","volume":"21","author":"Chandok","year":"2012","journal-title":"J Gastrointestin Liver Dis."},{"key":"B25","first-page":"43","article-title":"Prevalance of non-alcoholic fatty liver disease in hypothyroid patients and its correlation with serum ferritin levels","volume":"21","author":"Chaturvedi","year":"2020","journal-title":"J Indian Acad Clin Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jgh3.12019","article-title":"Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease","volume":"1","author":"El Nakeeb","year":"2017","journal-title":"JGH Open."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jhep.2010.09.037","article-title":"Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity","volume":"54","author":"Fracanzani","year":"2011","journal-title":"J Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jgh.13235","article-title":"The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease","volume":"31","author":"Goh","year":"2016","journal-title":"J Gastroenterol Hepatol Aust."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/liv.13144","article-title":"Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up","volume":"36","author":"Hagstr\u00f6m","year":"2016","journal-title":"Liver Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/j.dsx.2019.05.032","article-title":"Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease","volume":"13","author":"Hanafy","year":"2019","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"key":"B31","first-page":"2042","article-title":"Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH","volume":"109","author":"Kawanaka","year":"2012","journal-title":"J Jpn Soc Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3350\/cmh.2013.19.2.120","article-title":"Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease","volume":"19","author":"Kim","year":"2013","journal-title":"Clin Mol Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1590-8658(04)00094-5","article-title":"Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver","volume":"36","author":"Loguercio","year":"2004","journal-title":"Dig Liver Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1478-3231.2011.02488.x","article-title":"Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients","volume":"31","author":"Manousou","year":"2011","journal-title":"Liver Int."},{"key":"B36","first-page":"432","article-title":"Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease","volume":"47","author":"Moon","year":"2006","journal-title":"Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi."},{"key":"B37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15171\/mejdd.2018.96","article-title":"Correlation between serum ferritin level and histopathological disease severity in non-alcoholic fatty liver disease","volume":"10","author":"Mousavi","year":"2018","journal-title":"Middle East J Dig Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12664-015-0572-5","article-title":"Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India","volume":"34","author":"Parikh","year":"2015","journal-title":"Indian J Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/liv.13513","article-title":"Hepatic iron is the major determinant of serum ferritin in NAFLD patients","volume":"38","author":"Ryan","year":"2018","journal-title":"Liver Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4103\/jfmpc.jfmpc_158_17","article-title":"Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease","volume":"6","author":"Seyedian","year":"2017","journal-title":"J Fam Med Prim Care."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.clinbiochem.2011.09.017","article-title":"Some inflammatory cytokine levels, iron metabolism and oxidant stress markers in subjects with nonalcoholic steatohepatitis","volume":"44","author":"Uysal","year":"2011","journal-title":"Clin Biochem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.7754\/Clin.Lab.2019.181250","article-title":"Association between serum ferritin level and nonalcoholic fatty liver disease in a non-obese Chinese population: a cross-sectional study","volume":"65","author":"Yao","year":"2019","journal-title":"Clin Lab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s10620-009-0771-y","article-title":"Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation","volume":"55","author":"Yoneda","year":"2010","journal-title":"Dig Dis Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatol Baltim Md."},{"key":"B46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1386-6346(02)00246-2","article-title":"Nonalcoholic steatohepatitis: risk factors for liver fibrosis","volume":"24","author":"Shimada","year":"2002","journal-title":"Hepatol Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatol Baltim Md."},{"key":"B48","first-page":"12","article-title":"Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis","volume":"14","author":"Koruk","year":"2003","journal-title":"Turk J Gastroenterol."},{"key":"B49","first-page":"1089","volume":"29","author":"Qu","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"key":"B50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3138\/canlivj-2021-0002","article-title":"Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis","volume":"5","author":"Trasolini","year":"2022","journal-title":"Can Liver J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/DMSO.S361187","article-title":"Hyperferritinemia correlates to metabolic dysregulation and steatosis in Chinese biopsy-proven nonalcoholic fatty liver disease patients","volume":"15","author":"Wang","year":"2022","journal-title":"Diabetes Metab Syndr Obes Targets Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e24225","DOI":"10.1002\/jcla.24225","article-title":"The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults","volume":"36","author":"Yang","year":"2022","journal-title":"J Clin Lab Anal."},{"key":"B54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1055-9965.EPI-21-0754","article-title":"Serum biomarkers of iron status and risk of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease","volume":"31","author":"Yu","year":"2022","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2009.03.010","article-title":"What is the evidence for gender differences in ferritin and haemoglobin?","volume":"73","author":"Rushton","year":"2010","journal-title":"Crit Rev Oncol Hematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1590\/1806-9282.63.03.284","article-title":"Hyperferritinemia in patients with nonalcoholic fatty liver disease","volume":"63","author":"Barros","year":"2017","journal-title":"Rev Assoc Medica Bras."},{"key":"B58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00535-010-0305-6","article-title":"A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease","volume":"46","author":"Sumida","year":"2011","journal-title":"J Gastroenterol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis","volume":"21","author":"Lurie","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0002-9440(10)63489-X","article-title":"Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease","volume":"163","author":"Roskams","year":"2003","journal-title":"Am J Pathol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.934989\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:36:45Z","timestamp":1659501405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.934989\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":61,"alternative-id":["10.3389\/fmed.2022.934989"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.934989","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"article-number":"934989"}}